Norges Bank
ANIP icon

Norges Bank’s ANI Pharmaceuticals ANIP Stock Holding History

Norges Bank’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$793K Buy
+9,585
New +$769K ﹤0.01% 1593
2026
Q1 		– Sell
-9,585
Closed -$757K – 88
2025
Q4 		$757K Buy
+9,585
New +$830K ﹤0.01% 1536
2025
Q3 		– Sell
-9,585
Closed -$625K – 101
2025
Q2 		$625K Hold
9,585
– – ﹤0.01% 1600
2025
Q1 		$642K Buy
+9,585
New +$572K ﹤0.01% 1673

Other funds holding ANIP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
GACM
Global Alpha Capital Management Montreal, Quebec, Canada $1.67B AUM 35.09% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Norges Bank's ANIP Position: Q2 2026 in Review

Norges Bank opened a new position in ANI Pharmaceuticals (ANIP) in Q2 2026: 9,585 shares worth $793K. The stake represents ﹤0.01% of the portfolio and ranks #1593 among its holdings. This is a return to the name: Norges Bank previously reported a position in ANIP as recently as Q4 2025.

Norges Bank first reported a position in ANIP in Q1 2025 and has held it in 4 quarters since. 307 funds tracked by Wall St. Rank hold ANIP as of Q2 2026.

  • Norges Bank held 9,585 shares of ANI Pharmaceuticals worth $793K as of Q2 2026.
  • ANI Pharmaceuticals was a new Norges Bank position in Q2 2026.
  • ANI Pharmaceuticals made up ﹤0.01% of Norges Bank's portfolio in Q2 2026, its #1593 holding.
  • Norges Bank first reported a position in ANI Pharmaceuticals in Q1 2025 and has held it in 4 quarters since.
  • 307 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q2 2026.

Based on Norges Bank's 13F filing for Q2 2026, filed 12 Aug 2026.